SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGamma Communications Regulatory News (GAMA)

Share Price Information for Gamma Communications (GAMA)

Share Price is delayed by 15 minutes
Get Live Data
929.50    -27.50 (-2.87%)
Bid:
926.00
Ask:
935.50
Spread: 9.50 (1.026%)
Market Cap: £838.07m
GAMA Live PriceLast checked at - London Stock Exchange

Intraday Gamma Communications Share Chart

Statement re Possible Offer

12 Jun 2026 15:28

RNS Number : 1788I
Oakley Capital Limited
12 June 2026
Β 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

Β 

THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.8 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "CODE")

FOR IMMEDIATE RELEASE

12 June 2026

Β 

Β 

No intention to make an offer for Gamma Communications plc ("Gamma")

On 15 May 2026, Gamma confirmed that it was in discussions with a consortium comprising Oakley Capital Limited ("Oakley") and Giacom Limited ("Giacom").

It has since been clarified to Gamma that Oakley was acting as the potential offeror and that Giacom was in preliminary discussions with Oakley regarding a possible purchase of some of the assets of Gamma (but was not acting in a consortium or acting in concert with Oakley).

Oakley confirms that it is not intending to make an offer for Gamma.

This is a statement to which Rule 2.8 of the Code applies.

Under Note 2 on Rule 2.8 of the Code, Oakley reserves the right to set the restrictions in Rule 2.8 aside in the following circumstances:

a. with the agreement of the board of Gamma;

b. if a third party, including the consortium comprising Providence Equity Partners L.L.C. and Epiris LLP, announces a firm intention to make an offer for Gamma;

c. if Gamma announces a Rule 9 waiver (see Note 1 of the Notes on Dispensations from Rule 9) or a reverse takeover (as defined in the Code); and

d. if there has been a material change of circumstances (as determined by the Panel on Takeovers and Mergers).

The Panel on Takeovers and Mergers has agreed that the restrictions set out in Rule 2.8 of the Code resulting from this announcement do not apply to Giacom as it was not acting in a consortium or acting in concert with Oakley.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
OFDZLLFFQQLFBBQ
Date   Source Headline
2nd May 202310:09 amRNSTotal Voting Rights
20th Apr 20234:33 pmRNSPublication of Notice of AGM
13th Apr 202311:31 amRNSDirector/PDMR Shareholding
30th Mar 20237:00 amRNSDirector/PDMR Shareholding
29th Mar 202311:42 amRNSDirector/PDMR Shareholding
28th Mar 202312:43 pmRNSHolding(s) in Company
21st Mar 20237:01 amRNSFinal Results
21st Mar 20237:00 amRNSChair succession planning
16th Mar 20237:00 amRNSDirectorate Change
14th Mar 20239:43 amRNSDirector/PDMR Shareholding
1st Mar 20232:01 pmRNSTotal Voting Rights
1st Mar 20239:32 amRNSHolding(s) in Company
17th Feb 20237:30 amRNSDirector/PDMR Shareholding
1st Feb 20235:47 pmRNSTotal Voting Rights
27th Jan 202312:44 pmRNSHolding(s) in Company
18th Jan 20235:21 pmRNSHolding(s) in Company
17th Jan 202310:34 amRNSDirector/PDMR Shareholding
12th Jan 20237:00 amRNSFull year growth expectations remain unchanged
11th Jan 20232:30 pmRNSTotal Voting Rights
11th Jan 20231:28 pmRNSHolding(s) in Company
10th Jan 202311:47 amRNSHolding(s) in Company
6th Jan 20234:08 pmRNSHolding(s) in Company
20th Dec 20227:00 amRNSChange of Senior Independent Director
19th Dec 202211:58 amRNSHolding(s) in Company
16th Dec 20223:31 pmRNSHolding(s) in Company
15th Dec 20226:26 pmRNSDirector/PDMR Shareholding
5th Dec 20225:15 pmRNSTotal Voting Rights
30th Nov 20227:00 amRNSChief Executive Officer Appointment
15th Nov 20226:04 pmRNSDirector/PDMR Shareholding
15th Nov 20223:44 pmRNSHolding(s) in Company
9th Nov 20228:53 amRNSBlock listing Interim Review
8th Nov 20222:17 pmRNSHolding(s) in Company
1st Nov 20223:18 pmRNSTotal Voting Rights
28th Oct 20224:54 pmRNSChange of Registered Office
27th Oct 20224:49 pmRNSDirector/PDMR Shareholding
17th Oct 20226:23 pmRNSDirector/PDMR Shareholding
13th Oct 20222:14 pmRNSHolding(s) in Company
10th Oct 202211:29 amRNSDirector/PDMR Shareholding
3rd Oct 20225:59 pmRNSTotal Voting Rights
3rd Oct 20224:44 pmRNSNon-Executive Director Appointment
27th Sep 20222:44 pmRNSDirector/PDMR Shareholding
15th Sep 202211:13 amRNSHolding(s) in Company
13th Sep 20224:52 pmRNSDirector/PDMR Shareholding
7th Sep 20226:10 pmRNSHolding(s) in Company
6th Sep 20227:00 amRNSHalf-year Report
31st Aug 20224:04 pmRNSHolding(s) in Company
16th Aug 202211:52 amRNSDirector/PDMR Shareholding
5th Aug 20225:23 pmRNSHolding(s) in Company
3rd Aug 202210:09 amRNSHolding(s) in Company
2nd Aug 20222:18 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.